Jupiter Acquisition Corporation
JAQC
NASDAQ Capital Market10.34
USD
+0.00
- -
CIK
0001817868
ISIN
US4820821043
CUSIP
482082104
Return %
Stock
S&P500
1Y
3.30
18.21
3Y
7.15
64.38
5Y
7.15
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- James Norman Hauslein
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 11450 SE Dixie Highway Hobe Sound FL United States of America 33455
- IPO Date
- Oct 1, 2021
- CIK
- 0001817868
- Similar Companies
- Business
- Jupiter Acquisition Corporation (NASDAQ: JAQC) is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company does not have significant operations and focuses on identifying targets primarily in the consumer and technology, media and telecommunications (TMT) industries. Incorporated in 2020 and headquartered in Hobe Sound, Florida, it operates as a subsidiary of Jupiter Founders LLC. Jupiter Acquisition Corporation offers no core products or services beyond its SPAC structure, which provides merger-related financial instruments including units, Class A common stock and warrants issued during its initial public offering in 2021. The company targets public market access for private businesses through de-SPAC transactions without ongoing revenue-generating activities. In December 2023, Jupiter Acquisition Corporation mutually terminated its business combination agreement with Filament Health Corp., canceled a related stockholder meeting and announced redemption of all outstanding public shares effective December 26, 2023, due to failure to complete an initial business combination within its charter timeframe. The company ceased operations for winding up, with Nasdaq delisting its securities and SEC Form 15 filing to terminate Exchange Act registration thereafter. No further mergers, acquisitions or strategic developments have been reported as of late 2025.
Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public Shares
Jupiter Acquisition Corporation Announces Intent to Reconvene and Adjourn its Special Meeting of Stockholders to December 18, 2023
Jupiter Acquisition Corporation Announces Intent to Convene and Adjourn its Special Meeting of Stockholders to December 12, 2023